Faculty

Institution

Unit

Venue

Jonathan Said

Professor of Pathology and Laboratory Medicine

University of California, Los Angeles

Affiliations

David Geffen School of Medicine

Urology

School of Medicine

Pathology & Laboratory Medicine

Jonathan Said is currently serving as a David Geffen School Of Medicine Professor of Pathology and Laboratory Medicine at University of California, Los Angeles.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Jonathan Said

University of California, Los Angeles

Professor of Pathology and Laboratory Medicine

You can click a keyword to filter the displayed items

oncology immunology cancer research hematology cancer biology medicine dermatology pathology medicinal research lymphoid neoplasia tumor biology cancer treatment cancer care clinical pathology prostate cancer cancer genetics cancer immunotherapy cancer genomics virology oncogenes molecular cancer cellular therapy hematological malignancies anti-cancer agents leukemia histopathology tumor targeting gene expression cancer cells human pathology viral oncology surgical oncology surgical pathology cancer management cancer imaging genitourinary cancers enzyme inhibition clinical immunology cancer growth cancer risk cell regulation renal cell carcinoma cell death mammalian biology medical mycology genome biology cancer prevention general pathology apoptosis therapeutic efficacy cytogenetics primary effusion lymphoma molecular pathology immunopathology drug targeting clinical mycology reed-sternberg cells multiple myeloma breast oncology transcription regulation tumor suppressors paraffin sections immunoperoxidase study keratin proteins immunohistochemical study prognosis sarcoma-associated herpesvirus prostate cancer cells molecular regulation experimental pathology lymphoid neoplasms carcinoembryonic antigen ultrastructural study histone deacetylase inhibitors retroperitoneal lymph nodes t-cell lymphomas kidney cancer disease mechanism clinical translation molecular diagnostics

Notable Scholarly Works

Notable Federal Grants

Collaborators

Enhanced Chemoprevention of Prostate Cancer by Combining Arctigenin With Green Tea and Quercetin in Prostate-Specific Phosphatase and Tensin Homolog Knockout Mice. Biomolecules (2024)

Qiongyu HaoSusanne M. HenningClara E. MagyarJonathan SaidJin ZhongMatthew B. RettigJaydutt V. VadgamaPiwen Wang

neurologytumor targetingprostate-specific phosphataseanti-cancer agentsprotein sciencedrug targetingmolecular medicinemedicinal researchcancer treatmentprostate cancercancer researchchemoprevention strategiesenhanced chemopreventionpharmacologydrug discoveryurologyenzyme inhibitiononcology

High Omega-3, Low Omega-6 Diet With Fish Oil for Men With Prostate Cancer on Active Surveillance: The Capfish-3 Randomized Clinical Trial. Journal of Clinical Oncology (2024)

William J. AronsonTristan GroganPei LiangPatricia JardackAmana R. LiddellClaudia PerezDavid ElashoffJonathan SaidPinchas CohenLeonard S. MarksSusanne M. Henning

benign prostatic hyperplasiapublic healthmedical nutritionepidemiologyactive surveillanceprostate cancerprostatic diseasecancer researchdietary healthfish oilomega-3 fatty acidsclinical researchurologycancer careoncology

Orbital Indeterminate Cell Histiocytosis. Orbit (2024)

Angela J. OhConnie M. SearsAkhila A. VadivelanBrigitte N. GompertsNoah FedermanJonathan SaidKelsey A. Roelofs

developmental biologyorbital disorderorbit determination

Abstract Ct023: Phase 1 Trial of Cd19/Cd20 Bispecific Chimeric Antigen Receptor-Engineered NaïVe/Memory T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma. Cancer Research (2023)

Benjamin R. PuliafitoChristopher WalthersBrenda JiSanaz N. GhafouriJacob NaparstekJacqueline TrentJia M. ChenMobina RoshandellCaitlin HarrisMobina KherichaThomas SchweppeBeata Berent-MaozStanley B. GoslinerAmr AlmaktariMelanie Ayala CejaMartin S. Allen-AuerbachJonathan SaidKarla NawalyMonica MeadSven de VosPatricia A. YoungCaspian OliaiGary J. SchillerJohn M. TimmermanAntoni RibasYvonne Y. ChenSarah M. Larson

immunologypharmacologycell researcht-regulatory cellcancer immunotherapycell biologycancer researchrefractory non-hodgkin lymphomacancer treatmentlymphoid neoplasiacell therapymedicinal researchcellular therapyclinical trialscancer biologyclinical transplantationclinical researchleukemiaoncology

B-Lymphoblastic Leukemia Presenting With Eosinophilia: A Case Report and Review. Blood (2023)

David ShabsovichMichael J. MaranzanoJonathan SaidNam KuSheeja PullarkatGary J. Schiller

hematological malignancieshematologyb-lymphoblastic leukemiamedicineoncology

Cd70 is Consistently Expressed in Primary and Metastatic Clear Cell Renal Cell Carcinoma. Clinical Genitourinary Cancer (2023)

Rong Rong HuangZhengshan ChenNils KroegerAllan PantuckJonathan SaidHarriet M. KlugerBrian ShuchHuihui Ye

urologycancer researchnephrologygenitourinary cancers

CORRECTION: “the 5Th Edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7): 1720–1748. Leukemia (2023)

Rita AlaggioCatalina AmadorIoannis AnagnostopoulosAyoma D. AttygalleIguaracyra Barreto de Oliveira AraujoEmilio BertiGovind BhagatAnita Maria BorgesDaniel BoyerMariarita CalaminiciAmy ChadburnJohn K. C. ChanWah CheukWee-Joo ChngJohn K. ChoiShih-Sung ChuangSarah E. CouplandMagdalena CzaderSandeep S. DaveDaphne de JongArianna Di NapoliMing-Qing DuKojo S. Elenitoba-JohnsonJudith FerryJulia GeyerDita GratzingerJoan GuitartSumeet GujralMarian HarrisChristine J. HarrisonSylvia HartmannAndreas HochhausPatty M. JansenKennosuke KarubeWerner KempfJoseph KhouryHiroshi KimuraWolfram KlapperAlexandra E. KovachShaji KumarAlexander J. LazarStefano LazziLorenzo LeonciniNelson LeungVasiliki LeventakiXiao-Qiu LiMegan S. LimWei-Ping LiuAbner LouissaintAndrea MarcoglieseL. Jeffrey MedeirosMichael MichalRoberto N. MirandaChristina MitteldorfSantiago Montes-MorenoWilliam MoriceValentina NardiKikkeri N. NareshYasodha NatkunamSiok-Bian NgIlske OschliesGerman OttMarie ParrensMelissa PulitzerS. Vincent RajkumarAndrew C. RawstronKaren RechAndreas RosenwaldJonathan SaidClémentine SarkozyShahin SayedCaner SayginAnna SchuhWilliam SewellReiner SiebertAliyah R. SohaniRitsuro SuzukiReuben ToozeAlexandra Traverse-GlehenFrancisco VegaBeatrice VergierAshutosh D. WechalekarBrent WoodLuc XerriWenbin XiaoNorah Olubunmi AkinolaYassmine AkkariLuis M. AllendeKatsuyuki AozasaIguaracyra AraujoLuca ArcainiKirit M. ArdeshnaNaoko AsanoAndishe AttarbaschiChris M. BaconSharon Louise BarransTracy BatchelorMaxime BattistellaLinda B. BaughnAmir Behdad

hematologyglobal healthhaematolymphoid tumoursleukemiaoncologylymphoid neoplasms

Data From Cd19/Cd20 Bispecific Chimeric Antigen Receptor (Car) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma. (2023)

Sarah M. LarsonChristopher M. WalthersBrenda JiSanaz N. GhafouriJacob NaparstekJacqueline TrentJia Ming ChenMobina RoshandellCaitlin HarrisMobina KherichaThomas SchweppeBeata Berent-MaozStanley B. GoslinerAmr AlmaktariMelanie Ayala CejaMartin S. Allen-AuerbachJonathan SaidKarla NawalyMonica MeadSven de VosPatricia A. YoungCaspian OliaiGary J. SchillerJohn M. TimmermanAntoni RibasYvonne Y. Chen

cell therapyt-regulatory cellcancer immunotherapylymphoid neoplasiaimmunologymedicinal researchimmunotherapydermatologycellular therapyimmune responsespharmacologytherapeutic targetsclinical transplantationadaptive immune systemcancer cellsrefractory non-hodgkin lymphomareceptorsclinical immunology

Data From Programmed Death Ligand 1 is Expressed by Non–Hodgkin Lymphomas and Inhibits the Activity of Tumor-Associated T Cells. (2023)

David J. AndorskyReiko E. YamadaJonathan SaidGeraldine S. PinkusDavid J. BettingJohn M. Timmerman

apoptosiscancer immunotherapycell deathimmunologyhematologynon-hodgkin lymphomascancer researchimmune responsespharmacologydata sciencecancer treatmentlymphoid neoplasiaoncologycancer biology

Effect of Omega-3 Fatty Acid Diet on Prostate Cancer Progression and Cholesterol Efflux in Tumor-Associated Macrophages—Dependence on Gpr120. Prostate Cancer and Prostatic Diseases (2023)

Pei LiangSusanne M. HenningTristan GroganDavid ElashoffJonathan SaidPinchas CohenWilliam J. Aronson

prostate cancer progressionneurologycholesterol effluxhepatologyprostate cancercancer researchpharmacologyomega-3 fatty acidsurologycancer careoncologycancer biologytumor-associated macrophages

1
2
3
4
5
46
10 / page

Jonathan Said

Professor of Pathology and Laboratory Medicine

University of California, Los Angeles

Affiliations

David Geffen School of Medicine

Urology

School of Medicine

Pathology & Laboratory Medicine

Jonathan Said is currently serving as a David Geffen School Of Medicine Professor of Pathology and Laboratory Medicine at University of California, Los Angeles.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Jonathan Said

University of California, Los Angeles

Professor of Pathology and Laboratory Medicine

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Enhanced Chemoprevention of Prostate Cancer by Combining Arctigenin With Green Tea and Quercetin in Prostate-Specific Phosphatase and Tensin Homolog Knockout Mice. Biomolecules (2024)

Qiongyu HaoSusanne M. HenningClara E. MagyarJonathan SaidJin ZhongMatthew B. RettigJaydutt V. VadgamaPiwen Wang

High Omega-3, Low Omega-6 Diet With Fish Oil for Men With Prostate Cancer on Active Surveillance: The Capfish-3 Randomized Clinical Trial. Journal of Clinical Oncology (2024)

William J. AronsonTristan GroganPei LiangPatricia JardackAmana R. LiddellClaudia PerezDavid ElashoffJonathan SaidPinchas CohenLeonard S. MarksSusanne M. Henning

Orbital Indeterminate Cell Histiocytosis. Orbit (2024)

Angela J. OhConnie M. SearsAkhila A. VadivelanBrigitte N. GompertsNoah FedermanJonathan SaidKelsey A. Roelofs

developmental biologyorbital disorderorbit determination

Abstract Ct023: Phase 1 Trial of Cd19/Cd20 Bispecific Chimeric Antigen Receptor-Engineered NaïVe/Memory T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma. Cancer Research (2023)

B-Lymphoblastic Leukemia Presenting With Eosinophilia: A Case Report and Review. Blood (2023)

David ShabsovichMichael J. MaranzanoJonathan SaidNam KuSheeja PullarkatGary J. Schiller

hematological malignancieshematologyb-lymphoblastic leukemiamedicineoncology

Cd70 is Consistently Expressed in Primary and Metastatic Clear Cell Renal Cell Carcinoma. Clinical Genitourinary Cancer (2023)

Rong Rong HuangZhengshan ChenNils KroegerAllan PantuckJonathan SaidHarriet M. KlugerBrian ShuchHuihui Ye

urologycancer researchnephrologygenitourinary cancers

CORRECTION: “the 5Th Edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7): 1720–1748. Leukemia (2023)

hematologyglobal healthhaematolymphoid tumoursleukemiaoncologylymphoid neoplasms

Data From Cd19/Cd20 Bispecific Chimeric Antigen Receptor (Car) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma. (2023)

Data From Programmed Death Ligand 1 is Expressed by Non–Hodgkin Lymphomas and Inhibits the Activity of Tumor-Associated T Cells. (2023)

David J. AndorskyReiko E. YamadaJonathan SaidGeraldine S. PinkusDavid J. BettingJohn M. Timmerman

apoptosiscancer immunotherapycell deathimmunologyhematologynon-hodgkin lymphomascancer researchimmune responsespharmacologydata sciencecancer treatmentlymphoid neoplasiaoncologycancer biology

Effect of Omega-3 Fatty Acid Diet on Prostate Cancer Progression and Cholesterol Efflux in Tumor-Associated Macrophages—Dependence on Gpr120. Prostate Cancer and Prostatic Diseases (2023)

Pei LiangSusanne M. HenningTristan GroganDavid ElashoffJonathan SaidPinchas CohenWilliam J. Aronson

prostate cancer progressionneurologycholesterol effluxhepatologyprostate cancercancer researchpharmacologyomega-3 fatty acidsurologycancer careoncologycancer biologytumor-associated macrophages

1
2
3
4
5
46
10 / page

Similar Faculty Members

Robert Anders

Institution

Johns Hopkins University

oncology

cancer research

Angelo De Marzo

Institution

Johns Hopkins University

urology

prostate cancer

Elizabeth Thompson

Institution

Johns Hopkins University

histopathology

immunology

Mary Kay Washington, Ph.D., M.D

Institution

Vanderbilt University

immunology

gastrointestinal oncology

Charles Eberhart

Institution

Johns Hopkins University

oncology

neurology

Ken Young

Institution

Duke University

oncology

immunology

Samuel French

Institution

University of California, Los Angeles

hepatology

pharmacology

Janice Mehnert

Institution

New York University

tumor targeting

radiation oncology

Michael A. Carducci

Institution

Johns Hopkins University

oncology

urology

David P Carbone

Institution

Ohio State University

applied artificial intelligence

multidisciplinary ai

Similar Faculty Members

Robert Anders

Institution

Johns Hopkins University

oncology

cancer research

Angelo De Marzo

Institution

Johns Hopkins University

urology

prostate cancer

Elizabeth Thompson

Institution

Johns Hopkins University

histopathology

immunology

Mary Kay Washington, Ph.D., M.D

Institution

Vanderbilt University

immunology

gastrointestinal oncology

Charles Eberhart

Institution

Johns Hopkins University

oncology

neurology

Ken Young

Institution

Duke University

oncology

immunology

Samuel French

Institution

University of California, Los Angeles

hepatology

pharmacology

Janice Mehnert

Institution

New York University

tumor targeting

radiation oncology

Michael A. Carducci

Institution

Johns Hopkins University

oncology

urology

David P Carbone

Institution

Ohio State University

applied artificial intelligence

multidisciplinary ai